Heather Whitaker
Overview
Explore the profile of Heather Whitaker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1000
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rose A, Lucaccioni H, Marsh K, Kirsebom F, Whitaker H, Emborg H, et al.
Euro Surveill
. 2025 Feb;
30(7).
PMID: 39980423
The 2024/25 influenza season in Europe is currently characterised by co-circulation of influenza A(H1N1)pdm09, A(H3N2) and B/Victoria viruses, with influenza A(H1N1)pdm09 predominating. Interim vaccine effectiveness (VE) estimates from eight European...
2.
Leston M, Kar D, Forbes A, Jamie G, Wimalaratna R, Jiwani G, et al.
Front Immunol
. 2024 Dec;
15:1491565.
PMID: 39697345
Background: Adults classified as immunosuppressed have been disproportionately affected by the COVID-19 pandemic. Compared to the immunocompetent, certain patients are at increased risk of suboptimal vaccine response and adverse health...
3.
Whitaker H, Findlay B, Zitha J, Goudie R, Hassell K, Evans J, et al.
Influenza Other Respir Viruses
. 2024 May;
18(5):e13284.
PMID: 38773753
Background: We report 2023/2024 season interim influenza vaccine effectiveness for three studies, namely, primary care in Great Britain, hospital settings in Scotland and hospital settings in England. Methods: A test...
4.
Gu X, Watson C, Agrawal U, Whitaker H, Elson W, Anand S, et al.
JMIR Public Health Surveill
. 2024 Apr;
10:e52047.
PMID: 38569175
Background: Prepandemic sentinel surveillance focused on improved management of winter pressures, with influenza-like illness (ILI) being the key clinical indicator. The World Health Organization (WHO) global standards for influenza surveillance...
5.
Cerqueira-Silva T, Pescarini J, Cardim L, Leyrat C, Whitaker H, de Brito C, et al.
Lancet Infect Dis
. 2024 Feb;
24(5):504-513.
PMID: 38342106
Background: Chikungunya virus outbreaks have been associated with excess deaths at the ecological level. Previous studies have assessed the risk factors for severe versus mild chikungunya virus disease. However, the...
6.
Leston M, Elson W, Ordonez-Mena J, Kar D, Whitaker H, Joy M, et al.
J Infect
. 2024 Feb;
88(3):106110.
PMID: 38302061
Background: Effective disease surveillance, including that for COVID-19, is compromised without a standardised method for categorising the immunosuppressed as a clinical risk group. Methods: We conducted a systematic review and...
7.
Kissling E, Maurel M, Emborg H, Whitaker H, McMenamin J, Howard J, et al.
Euro Surveill
. 2023 May;
28(21).
PMID: 37227299
BackgroundBetween October 2022 and January 2023, influenza A(H1N1)pdm09, A(H3N2) and B/Victoria viruses circulated in Europe with different influenza (sub)types dominating in different areas.AimTo provide interim 2022/23 influenza vaccine effectiveness (VE)...
8.
Tsang R, Joy M, Whitaker H, Sheppard J, Williams J, Sherlock J, et al.
Br J Gen Pract
. 2023 May;
73(731):e435-e442.
PMID: 37130611
Background: People with multiple health conditions are more likely to have poorer health outcomes and greater care and service needs; a reliable measure of multimorbidity would inform management strategies and...
9.
Callaghan C, Curtis R, Mumford L, Whitaker H, Pettigrew G, Gardiner D, et al.
Transplantation
. 2023 Feb;
107(5):1124-1135.
PMID: 36727724
Background: The effectiveness of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 Omicron variant in immunosuppressed solid organ and islet transplant (SOT) recipients is unclear. Methods: National...
10.
Whitaker H, Tsang R, Button E, Andrews N, Byford R, Borrow R, et al.
J Infect
. 2022 Apr;
84(6):814-824.
PMID: 35405169
Objectives: To monitor changes in seroprevalence of SARS-CoV-2 antibodies in populations over time and between different demographic groups. Methods: A subset of practices in the Oxford-Royal College of General Practitioners...